Boston Scientific Corporation
Boston Scientific Corporation/ US1011371077 /
BSX
|
11/11/2024 22:10:00
|
Chg.
+0.23
|
Volume |
Bid22:33:10 |
Ask22:33:10 |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
88.48USD
|
+0.26%
|
3.95 mill.
Turnover: 250.1 mill. |
88.52Bid Size: 100 |
89.00Ask Size: 100 |
130.4 bill.USD |
- |
81.93 |
Business description
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.
Management board & Supervisory board
| CEO |
| Michael F. Mahoney |
| Management board |
| Daniel J. Brennan, Brad Sorenson, Eric Thépaut, Jeff Mirviss, Jodi Eddy, Joseph M. Fitzgerald, Meghan Scanlon, Scott Olson, Vance R. Brown, Wendy Carruthers, Charlie Attlan, Lance Bates, Rosaleen Burke, Arthur C. Butcher, Michael Jones, Stephen Morse, Mary Beth Moynihan, Dr. Kenneth Stein |
| Supervisory board |
| Michael F. Mahoney, Charles J. Dockendorff, David S. Wichmann, Edward J. Ludwig, Ellen Zane, John E. Sununu, Nelda J. Connors, Yoshiaki Fujimori, Jessica L. Mega, Susan E. Morano, David Roux |
Company data
| Name: |
Boston Scientific Corp. |
| Address: |
300 Boston Scientific Way,Marlborough, Massachusetts 01752-1234, USA |
| Phone: |
+1-508-683-4000 |
| Fax: |
- |
| E-mail: |
-
|
| Internet: |
www.bsci.com |
| Industry: |
Healthcare |
| Sector: |
Medical Products |
| Sub sector: |
Advanced Medical Devices |
| End of financial year: |
31/12 |
| Free Float: |
- |
| IPO date: |
19/05/1992 |
